CTOs on the Move

Framingham Heart Study

www.framinghamheartstudy.org

 
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Framingham Heart Study raised $38M on 04/16/2019

Similar Companies

Etowah Landing Care

Etowah Landing is a post-acute care facility that provides a custom-tailored, medically driven rehabilitation program for fast recovery.

Delmont Labs

Delmont Labs is a Swarthmore, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Matrixx Initiatives Inc.

Matrixx Initiatives Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Scottsdale, AZ. To find more information about Matrixx Initiatives Inc., please visit www.matrixxinc.com

American Arthritis and Osteoporosis

American Arthritis & Osteoporosis Care Center owned and operated by Shereen Hashmi, M.D.

New York Genome Center

The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations are united in this unprecedented collaboration of technology, science, and medicine. We implement advanced genomic research, and integrate our findings with world-class technologies and physician-scientists in order to help solve diseases. We harness the diversity of New York`s institutions and people to drive scientific discoveries that will vastly improve clinical care — ethically, equitably and urgently. We advocate and educate, sharing our findings with the global scientific, medical and thought leadership communities to broaden the reach of the New York Genome Center to help patients in every corner of the world. We create synergies through collaboration to continually innovate and advance our vision.